[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334962-105":59,"doc-detail-334962-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","b-cell-lymphocytes-as-a-potential-source-of-breast-carcinoma-marker-candidates","B Cell Lymphocytes as a Potential Source of Breast Carcinoma Marker Candidates","","Despite advances in genomic breast cancer classification, current clinical testing and treatment decisions rely on protein-level information, particularly immunohistochemical determination of ESR1, PGR, HER2, and Ki-67. Although tumor-infiltrating T cells have been widely linked to prognosis, the role of tumor-infiltrating B cells remains less explored. This study correlates immunohistochemical results with a proteomic strategy measuring proteins from B-cell lymphocytes in peripheral blood. Shotgun proteomics enabled comprehensive, untargeted characterization and identified 18 proteins with significant fold change (>2) as candidate biomarkers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/b-cell-lymphocytes-as-a-potential-source-of-breast-carcinoma-marker-candidates/334962/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/b-cell-lymphocytes-as-a-potential-source-of-breast-carcinoma-marker-candidates/334962.png","ImageObject",300,407,{"name":92,"@type":93},"Maeve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical biomarkers are commonly used to guide breast cancer decisions?","Question",{"text":112,"@type":113},"Clinical decisions frequently use immunohistochemical detection of ESR1, PGR, HER2, and the proliferation marker Ki-67.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why does the study focus on B cells rather than tumor-infiltrating T cells?",{"text":117,"@type":113},"Tumor-infiltrating T cells have been widely investigated for prognostic relevance, while tumor-infiltrating B cells have received less attention.",{"name":119,"@type":110,"acceptedAnswer":120},"How were candidate breast cancer biomarkers identified in this work?",{"text":121,"@type":113},"The study used shotgun proteomic analysis on proteins isolated from B-cell lymphocytes in peripheral blood, identifying 18 proteins with significant fold change (>2) as promising candidates.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334962,1790179533,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","Article  \nB Cell Lymphocytes as a Potential Source of Breast Carcinoma Marker Candidates  \nSo ˇna Tkáˇciková 1, *, Miroslav Marcin 1, Peter Bober 1, Mária Kacírová 2, Michaela Šuliková 1, Jozef Parnica 1, Dávid Tóth 3, Marek Lenárt 4, Jozef Rado ˇnak 4, Peter Urdzík 3, Ján Fedaˇcko 2 and Ján Sabo 1, *  \nCitation: Tkáˇciková, S.; Marcin, M.; Bober, P.; Kacírová, M.; Šuliková, M.; Parnica, J.; Tóth, D.; Lenárt, M.; Rado ˇnak, J.; Urdzík, P.; et al. B Cell Lymphocytes as a Potential Source of Breast Carcinoma Marker Candidates. Int. J. Mol. Sci. 2024, 25, 7351. [https://](https://)[ ](https://)[doi.org/10.3390/ijms25137351](doi.org/10.3390/ijms25137351)  \nAcademic Editors: Peter J. K. Kuppen and Antonio Lucacchini  \nReceived: 25 April 2024  \nRevised: 1 July 2024  \nAccepted: 1 July 2024  \nPublished: 4 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Medical and Clinical Biophysics, Faculty of Medicine, University of Pavol Jozef Šafárik in Košice, Trieda SNP 1, 04011 Košice, Slovakia; [miroslav.marcin@upjs.sk](miroslav.marcin@upjs.sk) (M.M.); [peter.bober@upjs.sk](peter.bober@upjs.sk) (P.B.); [michaela.sulikova@upjs.sk](michaela.sulikova@upjs.sk) (M.Š .); [jozef.parnica@upjs.sk](jozef.parnica@upjs.sk) (J.P.)  \n2 Center of Clinical and Preclinical Research MEDIPARK, Faculty of Medicine, University of Pavol Jozef Šafárikin Košice, Trieda SNP 1, 04011 Košice, Slovakia; [maria.kacirova@upjs.sk](maria.kacirova@upjs.sk) (M.K.); [jan.fedacko@upjs.sk](jan.fedacko@upjs.sk) (J.F.)  \n3 Department of Gynaecology and Obstetrics, Faculty of Medicine, University of Pavol Jozef Šafárik and UNLPin Košice, Trieda SNP 1, 04011 Košice, Slovakia; [david.toth@upjs.sk](david.toth@upjs.sk) (D.T.); [peter.urdzik@upjs.sk](peter.urdzik@upjs.sk) (P.U.)  \n4 1st Department of Surgery, Faculty of Medicine, University of Pavol Jozef Šafárik and UNLP in Košice, Trieda SNP 1, 04011 Košice, Slovakia; [marek.lenart@student.upjs.sk](marek.lenart@student.upjs.sk) (M.L.); [jozef.radonak@upjs.sk](jozef.radonak@upjs.sk) (J.R.)  \n* Correspondence: [sona.tkacikova@upjs.sk](sona.tkacikova@upjs.sk) (S.T.); [jan.sabo@upjs.sk](jan.sabo@upjs.sk) (J.S.)  \nAbstract: Despite advances in the genomic classification of breast cancer, current clinical tests and treatment decisions are commonly based on protein-level information. Nowadays breast cancer clinical treatment selection is based on the immunohistochemical (IHC) determination of four protein biomarkers: Estrogen Receptor 1 (ESR1), Progesterone Receptor (PGR), Human Epidermal Growth Factor Receptor 2 (HER2), and proliferation marker Ki-67 . The prognostic correlation of tumorinfiltrating T cells has been widely studied in breast cancer, but tumor-infiltrating B cells have not received so much attention. We aimed to find a correlation between immunohistochemical results and a proteomic approach in measuring the expression of proteins isolated from B-cell lymphocytes in peripheral blood samples. Shotgun proteomic analysis was chosen for its key advantage over other proteomic methods, which is its comprehensive and untargeted approach to analyzing proteins. This approach facilitates better characterization of disease-associated changes at the protein level. We identified 18 proteins in B cell lymphocytes with a significant fold change of more than 2, which have promising potential to serve as breast cancer biomarkers in the future.  \nKeywords: peripheral blood; lymphocyte B; carcinoma; proteomic analysis; mass spectrometry; CD19+ marker  \n1. Introduction  \nBreast cancer (BC) is the most common cancer in women, with 2.3 million new cases diagnosed per year, leading to 690,000 deaths annually [1] . T","cbCainkgpJ7NJ2cU","https://ap.wps.com/l/cbCainkgpJ7NJ2cU","pdf",2333286,"English","# Introduction\n## Breast cancer subtypes and biomarker-based classification\n## Rationale for focusing on B-cell lymphocytes\n# Abstract\n## Immunohistochemistry and protein biomarkers\n## Shotgun proteomic approach\n## Identified candidate proteins","[{\"question\":\"What clinical biomarkers are commonly used to guide breast cancer decisions?\",\"answer\":\"Clinical decisions frequently use immunohistochemical detection of ESR1, PGR, HER2, and the proliferation marker Ki-67.\"},{\"question\":\"Why does the study focus on B cells rather than tumor-infiltrating T cells?\",\"answer\":\"Tumor-infiltrating T cells have been widely investigated for prognostic relevance, while tumor-infiltrating B cells have received less attention.\"},{\"question\":\"How were candidate breast cancer biomarkers identified in this work?\",\"answer\":\"The study used shotgun proteomic analysis on proteins isolated from B-cell lymphocytes in peripheral blood, identifying 18 proteins with significant fold change (\\u003e2) as promising candidates.\"}]","B Cell Lymphocytes as a Potential Source of Breast Carcinoma Marker Candidates | PDF",1790009043,48]